Connection

Alessandro Bartoloni to Aged

Back to Details
This is a "connection" page, showing publications Alessandro Bartoloni has written about Aged.
Alessandro Bartoloni
Connection Strength
0.118
Aged
  1. Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures. Trop Med Int Health. 2017 11; 22(11):1457-1462.
    View in: PubMed
    Score: 0.013
  2. The role of Quantiferon-TB Gold in-Tube in the diagnosis and treatment monitoring of active tuberculosis. Infect Dis (Lond). 2017 Jun; 49(6):474-477.
    View in: PubMed
    Score: 0.013
  3. Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability. J Am Med Dir Assoc. 2021 08; 22(8):1588-1592.e1.
    View in: PubMed
    Score: 0.004
  4. First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19. J Clin Invest. 2021 06 15; 131(12).
    View in: PubMed
    Score: 0.004
  5. Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome. Eur J Endocrinol. 2021 May 28; 185(1):137-144.
    View in: PubMed
    Score: 0.004
  6. High-dose steroids for the treatment of severe COVID-19. Intern Emerg Med. 2021 08; 16(5):1395-1399.
    View in: PubMed
    Score: 0.004
  7. The impact of COVID-19 pandemic on frail health systems of low- and middle-income countries: The case of epilepsy in the rural areas of the Bolivian Chaco. Epilepsy Behav. 2021 05; 118:107917.
    View in: PubMed
    Score: 0.004
  8. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.004
  9. Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020 12; 161(4):345-353.
    View in: PubMed
    Score: 0.004
  10. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study. BMJ Open. 2020 09 25; 10(9):e040729.
    View in: PubMed
    Score: 0.004
  11. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
    View in: PubMed
    Score: 0.004
  12. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.004
  13. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
    View in: PubMed
    Score: 0.004
  14. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
    View in: PubMed
    Score: 0.004
  15. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020 04; 25(17).
    View in: PubMed
    Score: 0.004
  16. How radiology can help pulmonary tuberculosis diagnosis: analysis of 49 patients. Radiol Med. 2019 Sep; 124(9):838-845.
    View in: PubMed
    Score: 0.004
  17. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum ß-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul; 54(1):49-54.
    View in: PubMed
    Score: 0.004
  18. The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa. Infection. 2019 Jun; 47(3):447-459.
    View in: PubMed
    Score: 0.004
  19. Invasive Meningococcal Disease due to group C N. meningitidis ST11 (cc11): The Tuscany cluster 2015-2016. Vaccine. 2018 09 25; 36(40):5962-5966.
    View in: PubMed
    Score: 0.003
  20. Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases. Eur J Gastroenterol Hepatol. 2018 07; 30(7):756-760.
    View in: PubMed
    Score: 0.003
  21. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis. PLoS One. 2018; 13(6):e0197825.
    View in: PubMed
    Score: 0.003
  22. Seroprevalence of Taenia solium antibodies in a cohort of Bolivian immigrants in Italy. Acta Trop. 2018 Sep; 185:107-109.
    View in: PubMed
    Score: 0.003
  23. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia - The SCELTA Trial. Circ J. 2018 05 25; 82(6):1688-1698.
    View in: PubMed
    Score: 0.003
  24. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
    View in: PubMed
    Score: 0.003
  25. Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. Clin Microbiol Infect. 2017 May; 23(5):335.e1-335.e5.
    View in: PubMed
    Score: 0.003
  26. Severe malaria in Europe: an 8-year multi-centre observational study. Malar J. 2017 01 31; 16(1):57.
    View in: PubMed
    Score: 0.003
  27. Absence of HIV infection in low- and high-risk groups in the Santa Cruz region, Bolivia. AIDS. 1989 Mar; 3(3):184-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.